Pertuzumab-Trastuzumab Combo Ups Infusion Reaction Risk in BCa Pertuzumab-Trastuzumab Combo Ups Infusion Reaction Risk in BCa

The risk of infusion reaction goes up in those with higher baseline lymphocyte counts. The study covered in this summary was published as a preprint and has not yet been peer reviewed.First Look
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news